Search results
Results from the WOW.Com Content Network
Until 2020, Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University. From 2013 through spring of 2016 he was also the Chief Innovation Officer, Allegheny Health Network. He is married to Maria Caruso and has five children: Hannah, Nessa, Christian, Trevor, and ...
However, there are some technologies The resulting amount, nearly $4.8 trillion, is what the federal government says we will spend by 2021. 3 Disruptive Technologies That Could Slash Health-Care Costs
The term disruptive technologies was coined by Clayton M. Christensen and introduced in his 1995 article Disruptive Technologies: Catching the Wave, [11] which he cowrote with Joseph Bower. The article is aimed at both management executives who make the funding or purchasing decisions in companies, as well as the research community, which is ...
Clayton Magleby Christensen (April 6, 1952 – January 23, 2020) was an American academic and business consultant who developed the theory of "disruptive innovation", which has been called the most influential business idea of the early 21st century.
This is a list of emerging technologies, which are in-development technical innovations that have significant potential in their applications. The criteria for this list is that the technology must: Exist in some way; purely hypothetical technologies cannot be considered emerging and should be covered in the list of hypothetical technologies ...
As people lived longer and medical technology advanced, the US healthcare system evolved into a convoluted patchwork of for-profit providers, government programs such as Medicare and Medicaid, and ...
Change Healthcare is a key player in the U.S. healthcare system that depends heavily on insurance, processing about 50% of medical claims for around 900,000 physicians, 33,000 pharmacies, 5,500 ...
HealthCap invests in companies developing disruptive technologies that hold the potential to change clinical practice. Over the years HealthCap has invested in more than 125 companies. The portfolio companies have developed more than 20 pharmaceutical products and over 40 med-tech products to the market. [8]